Cytokinetics, Incorporated (CYTK)
USD 35.47
(-5.06%)
USD 35.47
(-5.06%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -456.68 Million USD | -54.8% |
| 2022 | -329.4 Million USD | -68.22% |
| 2021 | -176.34 Million USD | -109.88% |
| 2020 | -86.78 Million USD | 4.76% |
| 2019 | -93.03 Million USD | -9.81% |
| 2018 | -83.48 Million USD | 23.53% |
| 2017 | -108.89 Million USD | -692.89% |
| 2016 | 14.92 Million USD | 149.96% |
| 2015 | -36.66 Million USD | -153.54% |
| 2014 | -14.15 Million USD | 56.47% |
| 2013 | -33.28 Million USD | 13.44% |
| 2012 | -39.77 Million USD | 14.09% |
| 2011 | -46.52 Million USD | 8.17% |
| 2010 | -47.4 Million USD | -290.54% |
| 2009 | 27.12 Million USD | 150.41% |
| 2008 | -53.42 Million USD | 3.69% |
| 2007 | -45.36 Million USD | 8.14% |
| 2006 | -53.65 Million USD | -40.51% |
| 2005 | -38.68 Million USD | -18.24% |
| 2004 | -33.38 Million USD | -19.55% |
| 2003 | -29.4 Million USD | -39.17% |
| 2002 | -21.13 Million USD | -14.9% |
| 2001 | -18.39 Million USD | -33.34% |
| 2000 | -13.79 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -123.9 Million USD | -2.2% |
| 2024 Q2 | -127.76 Million USD | -0.54% |
| 2023 Q2 | -115.27 Million USD | 2.35% |
| 2023 Q1 | -118.04 Million USD | 2.53% |
| 2023 Q4 | -121.08 Million USD | -4.9% |
| 2023 FY | - USD | -54.8% |
| 2023 Q3 | -115.42 Million USD | -0.14% |
| 2022 Q3 | -102.88 Million USD | -927.86% |
| 2022 Q4 | -121.11 Million USD | -17.71% |
| 2022 Q1 | -77.44 Million USD | -256.81% |
| 2022 FY | - USD | -68.22% |
| 2022 Q2 | -10.01 Million USD | 87.07% |
| 2021 Q2 | -54.06 Million USD | -35.9% |
| 2021 Q3 | -68.97 Million USD | -27.56% |
| 2021 Q4 | -21.7 Million USD | 68.53% |
| 2021 FY | - USD | -109.88% |
| 2021 Q1 | -39.78 Million USD | -16.12% |
| 2020 Q2 | -30.97 Million USD | -5.97% |
| 2020 Q3 | 6.26 Million USD | 120.22% |
| 2020 FY | - USD | 4.76% |
| 2020 Q4 | -34.26 Million USD | -647.13% |
| 2020 Q1 | -29.23 Million USD | -32.96% |
| 2019 Q4 | -21.98 Million USD | 4.02% |
| 2019 Q1 | -23.09 Million USD | -12.32% |
| 2019 FY | - USD | -9.81% |
| 2019 Q2 | -25.67 Million USD | -11.18% |
| 2019 Q3 | -22.9 Million USD | 10.77% |
| 2018 Q1 | -25.28 Million USD | 29.27% |
| 2018 Q2 | -22.28 Million USD | 11.87% |
| 2018 Q3 | -16.59 Million USD | 25.56% |
| 2018 Q4 | -20.55 Million USD | -23.92% |
| 2018 FY | - USD | 23.53% |
| 2017 Q2 | -25.19 Million USD | -8.36% |
| 2017 FY | - USD | -692.89% |
| 2017 Q3 | -28.42 Million USD | -12.82% |
| 2017 Q1 | -23.25 Million USD | -402.43% |
| 2017 Q4 | -35.75 Million USD | -25.78% |
| 2016 Q2 | -11.01 Million USD | 7.89% |
| 2016 Q1 | -11.95 Million USD | -32.51% |
| 2016 FY | - USD | 149.96% |
| 2016 Q3 | 32.49 Million USD | 395.07% |
| 2016 Q4 | 7.68 Million USD | -76.34% |
| 2015 Q4 | -9.02 Million USD | -1.5% |
| 2015 FY | - USD | -153.54% |
| 2015 Q3 | -8.88 Million USD | 16.06% |
| 2015 Q2 | -10.58 Million USD | -18.86% |
| 2015 Q1 | -8.9 Million USD | -205.8% |
| 2014 Q3 | -5.99 Million USD | 28.65% |
| 2014 Q4 | 8.42 Million USD | 240.4% |
| 2014 Q1 | -8.77 Million USD | -236.35% |
| 2014 FY | - USD | 56.47% |
| 2014 Q2 | -8.4 Million USD | 4.14% |
| 2013 Q3 | -12.61 Million USD | 16.31% |
| 2013 FY | - USD | 13.44% |
| 2013 Q4 | 6.43 Million USD | 151.0% |
| 2013 Q2 | -15.06 Million USD | -19.14% |
| 2013 Q1 | -12.64 Million USD | -24.81% |
| 2012 Q3 | -10.07 Million USD | -12.19% |
| 2012 Q4 | -10.13 Million USD | -0.56% |
| 2012 FY | - USD | 14.09% |
| 2012 Q1 | -10.02 Million USD | 3.51% |
| 2012 Q2 | -8.98 Million USD | 10.38% |
| 2011 Q1 | -11.75 Million USD | -5.59% |
| 2011 Q2 | -13.64 Million USD | -16.12% |
| 2011 Q3 | -10.66 Million USD | 21.83% |
| 2011 Q4 | -10.38 Million USD | 2.63% |
| 2011 FY | - USD | 8.17% |
| 2010 Q4 | -11.13 Million USD | 11.42% |
| 2010 FY | - USD | -290.54% |
| 2010 Q1 | -12.28 Million USD | -8.8% |
| 2010 Q2 | -13.15 Million USD | -7.09% |
| 2010 Q3 | -12.56 Million USD | 4.48% |
| 2009 Q3 | -8.25 Million USD | -113.81% |
| 2009 Q4 | -11.29 Million USD | -36.85% |
| 2009 FY | - USD | 150.41% |
| 2009 Q1 | -10.44 Million USD | 1.61% |
| 2009 Q2 | 59.75 Million USD | 672.13% |
| 2008 Q3 | -11.1 Million USD | 27.87% |
| 2008 Q1 | -14.55 Million USD | -1.76% |
| 2008 FY | - USD | 3.69% |
| 2008 Q4 | -10.61 Million USD | 4.45% |
| 2008 Q2 | -15.4 Million USD | -5.85% |
| 2007 FY | - USD | 8.14% |
| 2007 Q4 | -14.29 Million USD | -14.12% |
| 2007 Q3 | -12.53 Million USD | 9.33% |
| 2007 Q2 | -13.81 Million USD | -6.23% |
| 2007 Q1 | -13 Million USD | 20.06% |
| 2006 Q1 | -12.71 Million USD | -16.11% |
| 2006 Q3 | -15.27 Million USD | -7.99% |
| 2006 Q4 | -16.27 Million USD | -6.54% |
| 2006 FY | - USD | -40.51% |
| 2006 Q2 | -14.14 Million USD | -11.23% |
| 2005 Q2 | -10.33 Million USD | -0.1% |
| 2005 Q3 | -9.96 Million USD | 3.49% |
| 2005 FY | - USD | -18.24% |
| 2005 Q4 | -10.95 Million USD | -9.87% |
| 2005 Q1 | -10.32 Million USD | 10.07% |
| 2004 Q2 | -8.7 Million USD | -69.08% |
| 2004 Q3 | -9.82 Million USD | -12.89% |
| 2004 Q1 | -5.14 Million USD | 87.29% |
| 2004 Q4 | -11.47 Million USD | -16.76% |
| 2004 FY | - USD | -19.55% |
| 2003 Q1 | -5 Million USD | 0.0% |
| 2003 FY | - USD | -39.17% |
| 2003 Q4 | -40.52 Million USD | -1632.64% |
| 2003 Q3 | 2.64 Million USD | 155.87% |
| 2003 Q2 | -4.73 Million USD | 5.49% |
| 2002 FY | - USD | -14.9% |
| 2001 FY | - USD | -33.34% |
| 2000 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -137.661% |
| Alkermes plc | 495.04 Million USD | 192.25% |
| Agenus Inc. | -145.92 Million USD | -212.96% |
| Aptorum Group Limited | -9.59 Million USD | -4657.622% |
| Ardelyx, Inc. | -55.35 Million USD | -725.024% |
| Dyadic International, Inc. | -8.22 Million USD | -5449.192% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -156836.082% |
| Lantern Pharma Inc. | -15.78 Million USD | -2792.842% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2193.466% |
| Novavax, Inc. | -487.39 Million USD | 6.3% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -543.0% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -481.815% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2440.881% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4481.501% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -695.95% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -20.19% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1794.019% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 86429.679% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -190.521% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -510.419% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2165.41% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1824.095% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1880.588% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -274.015% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -76.843% |
| AlloVir, Inc. | -190.14 Million USD | -140.175% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -159.964% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1460.886% |
| Bicycle Therapeutics plc | -183.4 Million USD | -149.01% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -176.074% |
| ChromaDex Corporation | -3.89 Million USD | -11627.889% |
| Chimerix, Inc. | -92.97 Million USD | -391.195% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -927.718% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -305.819% |
| CRISPR Therapeutics AG | -202.7 Million USD | -125.299% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1325.267% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -165.161% |
| Fortress Biotech, Inc. | -133.64 Million USD | -241.719% |
| Fortress Biotech, Inc. | -133.64 Million USD | -241.719% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -490.466% |
| ImmuCell Corporation | -2.5 Million USD | -18137.618% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -250.161% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2730.28% |
| Incyte Corporation | 919.42 Million USD | 149.671% |
| Innoviva, Inc. | 248.96 Million USD | 283.437% |
| IO Biotech, Inc. | -91.22 Million USD | -400.596% |
| Jaguar Health, Inc. | -33.13 Million USD | -1278.419% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -200.101% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 548.931% |
| ContextLogic Inc. | -324 Million USD | -40.952% |
| MiMedx Group, Inc. | 40.51 Million USD | 1227.142% |
| MEI Pharma, Inc. | 26.38 Million USD | 1831.175% |
| NextCure, Inc. | -59.03 Million USD | -673.529% |
| Onconetix, Inc. | -36.7 Million USD | -1144.143% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 20533.289% |
| Opthea Limited | -200.01 Million USD | -128.321% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -16497.155% |
| Vaxcyte, Inc. | -464.88 Million USD | 1.764% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1039.29% |
| Precigen, Inc. | -89.22 Million USD | -411.828% |
| Pharming Group N.V. | 9.87 Million USD | 4723.712% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -187.134% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1906.344% |
| PureTech Health plc | -11.62 Million USD | -3827.789% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2589.382% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -95.585% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1794.019% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -422.36% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1476.784% |
| Acelyrin, Inc. | -381.52 Million USD | -19.699% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3544237.592% |
| Summit Therapeutics Inc. | 1 Million USD | 45722.777% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1267.891% |
| Senti Biosciences, Inc. | -61.33 Million USD | -644.561% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -306.65% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1001.319% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1377.75% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -7366.371% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -142169.159% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1307.217% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -5339.304% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -676.806% |
| Seer, Inc. | -97.88 Million USD | -366.552% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -634.254% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -598.667% |
| ESSA Pharma Inc. | -26.45 Million USD | -1626.247% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1067.333% |
| GT Biopharma, Inc. | 5.97 Million USD | 7738.133% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -120.948% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -6549.447% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 626.061% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -704.673% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -791.63% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -4519.079% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 15.418% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -6533.992% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -874.529% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -93.001% |
| Aptose Biosciences Inc. | -52.26 Million USD | -773.735% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -323.863% |
| Soligenix, Inc. | -7.85 Million USD | -5715.519% |
| Century Therapeutics, Inc. | -121.2 Million USD | -276.777% |
| Kura Oncology, Inc. | -164.95 Million USD | -176.854% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -470.157% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4427.9% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -47583.555% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -10498.375% |
| Autolus Therapeutics plc | -156.77 Million USD | -191.308% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -439.452% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -561.851% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2190.98% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -141.283% |
| GRI Bio, Inc. | -10.89 Million USD | -4090.53% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -10013.216% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -272.785% |
| IGM Biosciences, Inc. | -253.35 Million USD | -80.252% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -339.999% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1097.601% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2878.845% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2800.826% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -703.385% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -326.397% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -71.688% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -135.478% |
| Verastem, Inc. | -83.16 Million USD | -449.123% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -803.037% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -188.624% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -300.287% |
| Histogen Inc. | -10.5 Million USD | -4248.129% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3098.133% |
| Surrozen, Inc. | -41.13 Million USD | -1010.316% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2984.452% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 14240324.509% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -677.822% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -790.326% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2020.266% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5377.138% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -175.001% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -827.118% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1789.779% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2933.43% |
| Apollomics, Inc. | -171.74 Million USD | -165.905% |
| Amarin Corporation plc | -50.9 Million USD | -797.191% |
| Mesoblast Limited | -61.33 Million USD | -644.622% |
| Turnstone Biologics Corp. | -56.23 Million USD | -712.114% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -218.911% |
| Synaptogenix, Inc. | -8.3 Million USD | -5397.245% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2877.274% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -624.355% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9431.196% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 106543.47% |
| Exelixis, Inc. | 196.6 Million USD | 332.289% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1093.571% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -222.953% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 7.78% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3771.629% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 184830.762% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1447.767% |
| Gritstone bio, Inc. | -126.86 Million USD | -259.982% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -602.753% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -11317.254% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3877.737% |
| Insmed Incorporated | -654.73 Million USD | 30.249% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -20199.602% |
| MediWound Ltd. | -4.89 Million USD | -9233.415% |
| OmniAb, Inc. | -49.73 Million USD | -818.308% |
| Alector, Inc. | -142.89 Million USD | -219.601% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -434.546% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -775.746% |
| Zai Lab Limited | -366.57 Million USD | -24.582% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -57.132% |
| Aura Biosciences, Inc. | -83.69 Million USD | -445.646% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -102.746% |
| Immunic, Inc. | -99.11 Million USD | -360.776% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -246.84% |
| Veracyte, Inc. | -49.4 Million USD | -824.293% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -6365.012% |
| FibroGen, Inc. | -261.4 Million USD | -74.704% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3999.129% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6422.82% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2339.96% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 131.508% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1696.413% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1244.858% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1849.747% |
| Galecto, Inc. | -37.51 Million USD | -1117.207% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1093.477% |
| Fortrea Holdings Inc. | 167.3 Million USD | 372.973% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -240.098% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1513.097% |
| XBiotech Inc. | -35.76 Million USD | -1176.866% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -602.753% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -599.899% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -337.206% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1678.919% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1017.488% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 11.573% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -715.201% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -814665.125% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -292.559% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1959.96% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -94.281% |
| NexImmune, Inc. | -28.16 Million USD | -1521.315% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -8164.954% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3772.74% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 109.812% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1698.535% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3798.9% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -262.891% |
| Ainos, Inc. | -8.77 Million USD | -5105.504% |
| Pluri Inc. | -20.22 Million USD | -2158.017% |
| Prothena Corporation plc | -190.1 Million USD | -140.223% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -256.233% |
| Celularity Inc. | -183.94 Million USD | -148.271% |
| Rallybio Corporation | -72.37 Million USD | -531.014% |
| Cue Biopharma, Inc. | -46.05 Million USD | -891.67% |
| MeiraGTx Holdings plc | -57.05 Million USD | -700.47% |
| Omeros Corporation | -163.61 Million USD | -179.13% |
| Humacyte, Inc. | -96.45 Million USD | -373.454% |
| Immunocore Holdings plc | -59.64 Million USD | -665.619% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2257.444% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1774.344% |
| Blueprint Medicines Corporation | -474.61 Million USD | 3.777% |
| CalciMedica, Inc. | -34.18 Million USD | -1235.763% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -523.596% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -263.9% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -171.108% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -80.944% |
| Pulmatrix, Inc. | -12.64 Million USD | -3511.292% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1285.318% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -416.22% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 9.802% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -351.202% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1268.424% |
| Nutriband Inc. | -5.12 Million USD | -8816.515% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -955.38% |
| Vor Biopharma Inc. | -114.37 Million USD | -299.301% |
| Roivant Sciences Ltd. | -996.51 Million USD | 54.172% |
| Evogene Ltd. | -23.2 Million USD | -1868.126% |
| ProKidney Corp. | -147.66 Million USD | -209.262% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -607.653% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -298095.875% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 19.238% |
| CorMedix Inc. | -48.88 Million USD | -834.162% |
| BioLineRx Ltd. | -57.06 Million USD | -700.343% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -308.637% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -225981.188% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1157.702% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -474.323% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -461.637% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -65.764% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1385.634% |
| MediciNova, Inc. | -9.87 Million USD | -4522.322% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -262.617% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -29744.707% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1612.43% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -102.979% |
| Biomea Fusion, Inc. | -124.62 Million USD | -266.461% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -38.247% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1652.702% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -139.932% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -98.608% |
| Absci Corporation | -95.45 Million USD | -378.419% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1421.012% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -326.337% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -95.602% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1898.18% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -119.733% |
| Allakos Inc. | -189.91 Million USD | -140.468% |
| Imunon, Inc. | -19.87 Million USD | -2197.402% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -320.938% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 521.591% |
| BioAtla, Inc. | -122.24 Million USD | -273.593% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3771.629% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2797.557% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -52.079% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1001.851% |
| XOMA Corporation | -39.36 Million USD | -1060.215% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -360.116% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -288.172% |
| aTyr Pharma, Inc. | -52.17 Million USD | -775.242% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -444.871% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -207.26% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -94.694% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3244.935% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -5578.525% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2618.034% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 242108.203% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 201.048% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7048.393% |
| UroGen Pharma Ltd. | -63.83 Million USD | -615.458% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -572.435% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6187.805% |
| Orgenesis Inc. | -60.71 Million USD | -652.139% |
| Entera Bio Ltd. | -8.8 Million USD | -5087.233% |
| GH Research PLC | -41.15 Million USD | -1009.722% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1689.584% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -455.354% |
| Xencor, Inc. | -125.87 Million USD | -262.81% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -31913.291% |
| Replimune Group, Inc. | -230.19 Million USD | -98.387% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2165.565% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -4073.679% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7048.393% |
| Portage Biotech Inc. | -18.19 Million USD | -2409.391% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -29744.707% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -336.667% |
| OncoCyte Corporation | -23.12 Million USD | -1875.021% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3941.322% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3886.126% |
| Purple Biotech Ltd. | -22.22 Million USD | -1954.821% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -7024.555% |
| scPharmaceuticals Inc. | -46.06 Million USD | -891.477% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2464.246% |
| HilleVax, Inc. | -132.46 Million USD | -244.756% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4194.968% |
| Tharimmune, Inc. | -9.3 Million USD | -4809.214% |
| Genprex, Inc. | -31.06 Million USD | -1370.302% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -143.531% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1356.541% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -59675.393% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 302732.137% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2900241.486% |
| Savara Inc. | -59.13 Million USD | -672.3% |
| Curis, Inc. | -45.13 Million USD | -911.728% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1387.497% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2906.251% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -6273.817% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1608.252% |
| BeiGene, Ltd. | -1.12 Billion USD | 59.392% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2701.536% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -6.062% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -405.517% |
| Erasca, Inc. | -121.31 Million USD | -276.46% |
| bluebird bio, Inc. | -167.16 Million USD | -173.2% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -10051.34% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 247.183% |
| DBV Technologies S.A. | -85.98 Million USD | -431.139% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -10051.34% |
| Moderna, Inc. | -3.28 Billion USD | 86.089% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -971.802% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -7985.765% |
| Molecular Templates, Inc. | 1.43 Million USD | 32035.944% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -663.022% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -39.981% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -233.13% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -864.16% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -228.469% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -121.842% |
| MacroGenics, Inc. | 2.01 Million USD | 22741.745% |
| RenovoRx, Inc. | -11.39 Million USD | -3909.517% |
| Adicet Bio, Inc. | -136.53 Million USD | -234.481% |
| Prime Medicine, Inc. | -193.75 Million USD | -135.697% |
| Aditxt, Inc. | -25.45 Million USD | -1693.875% |
| Adagene Inc. | -14.95 Million USD | -2954.582% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6147.303% |
| Quantum-Si incorporated | -91.8 Million USD | -397.455% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 164.104% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 461.143% |
| SciSparc Ltd. | -5.28 Million USD | -8546.043% |
| Vericel Corporation | 2.86 Million USD | 16045.67% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -479569.776% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2005.366% |
| Generation Bio Co. | -133.3 Million USD | -242.599% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -450.023% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -430.886% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -100.798% |
| Invivyd, Inc. | -196.61 Million USD | -132.273% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -22.058% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -4823.924% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1781.83% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4340.292% |
| 2seventy bio, Inc. | -206.41 Million USD | -121.242% |
| ADMA Biologics, Inc. | 5.12 Million USD | 9019.609% |
| Clene Inc. | -43.24 Million USD | -956.137% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1884.808% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -842.063% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1612.43% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -52.449% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1143.376% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2037.318% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 9400.617% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1305.96% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -188.303% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 33.263% |
| Evaxion Biotech A/S | -21.4 Million USD | -2033.738% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -587.622% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -109.807% |
| Trevena, Inc. | -35.28 Million USD | -1194.162% |
| Surrozen, Inc. | -41.13 Million USD | -1010.316% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -473.781% |
| Cingulate Inc. | -22.95 Million USD | -1889.732% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -6020.949% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1124.912% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -5451.464% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -346.565% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -573.307% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -682.368% |
| Clearmind Medicine Inc. | -8.71 Million USD | -5142.816% |
| Kronos Bio, Inc. | -121.83 Million USD | -274.853% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -514.301% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -18605.717% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -352.938% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1272.941% |
| ImmunityBio, Inc. | -436.18 Million USD | -4.7% |
| Korro Bio, Inc. | -80.9 Million USD | -464.476% |
| Kineta, Inc. | -15.71 Million USD | -2806.224% |
| BioVie Inc. | -31.95 Million USD | -1329.362% |
| Codexis, Inc. | -49.28 Million USD | -826.656% |
| Celularity Inc. | -183.94 Million USD | -148.271% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -106.169% |
| Celcuity Inc. | -58.3 Million USD | -683.201% |
| Virax Biolabs Group Limited | -6.6 Million USD | -6809.881% |
| Cibus, Inc. | -314.58 Million USD | -45.17% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1253.82% |
| IN8bio, Inc. | -28.5 Million USD | -1502.175% |
| Kodiak Sciences Inc. | -259.02 Million USD | -76.31% |
| Annexon, Inc. | -141.57 Million USD | -222.574% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -305.584% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -611.39% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1533.64% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -98.55% |
| Eyenovia, Inc. | -24.1 Million USD | -1794.48% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1119.748% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -140851.852% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -518.779% |
| Arcellx, Inc. | -64.14 Million USD | -611.956% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -914.538% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -269.856% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1378.803% |
| Moolec Science SA | -52.07 Million USD | -776.965% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -784.944% |
| Geron Corporation | -174.78 Million USD | -161.288% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1029.93% |
| Royalty Pharma plc | 1.88 Billion USD | 124.198% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -281.865% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4797.807% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2101.868% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -174.978% |
| Humacyte, Inc. | -96.45 Million USD | -373.454% |
| Structure Therapeutics Inc. | -102.45 Million USD | -345.724% |
| 89bio, Inc. | -134.46 Million USD | -239.635% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -478.997% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 11370.582% |
| Genelux Corporation | -24.16 Million USD | -1789.857% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1251.136% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -179.379% |
| Notable Labs, Ltd. | -14.4 Million USD | -3071.417% |
| Liquidia Corporation | -70.05 Million USD | -551.931% |
| Mustang Bio, Inc. | -48.06 Million USD | -850.178% |
| Immunovant, Inc. | -269.97 Million USD | -69.156% |
| Quantum-Si incorporated | -91.8 Million USD | -397.455% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -543.344% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2265.258% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -347.677% |
| Acasti Pharma Inc. | -11.3 Million USD | -3941.094% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1952.213% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2878.845% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -116.939% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -10594.317% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2775.844% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1487.031% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1133.281% |
| PepGen Inc. | -83.58 Million USD | -446.39% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1447.871% |
| United Therapeutics Corporation | 1.38 Billion USD | 132.931% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1894.515% |
| Solid Biosciences Inc. | -93.43 Million USD | -388.777% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -9470.605% |
| Immuneering Corporation | -58.06 Million USD | -686.562% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 14240324.509% |
| Silo Pharma, Inc. | -3.62 Million USD | -12493.962% |
| Belite Bio, Inc | -31.52 Million USD | -1348.457% |
| XOMA Corporation | -39.36 Million USD | -1060.215% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -577.101% |
| Bionomics Limited | -9.83 Million USD | -4542.515% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -443.769% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1219.667% |
| uniQure N.V. | -253.1 Million USD | -80.436% |
| Cassava Sciences, Inc. | -95.68 Million USD | -377.269% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6147.303% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -252.641% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1306.177% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -5572.76% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1518.356% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -140851.852% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3999.129% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2772.046% |
| Altimmune, Inc. | -87.93 Million USD | -419.343% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -395.97% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1219.667% |
| Compugen Ltd. | -12.51 Million USD | -3548.802% |
| Peak Bio, Inc. | -1356.23 USD | -33672949.556% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -839.718% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1930.609% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -88.476% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1499.986% |
| Zura Bio Limited | -60.56 Million USD | -654.064% |
| PolyPid Ltd. | -20.26 Million USD | -2153.783% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2825.024% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1499.986% |
| Instil Bio, Inc. | -146.12 Million USD | -212.536% |
| argenx SE | -216.02 Million USD | -111.405% |
| Immunome, Inc. | -28.27 Million USD | -1515.38% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -842.141% |
| Verona Pharma plc | -52.46 Million USD | -770.412% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -381.877% |
| Shattuck Labs, Inc. | -87.61 Million USD | -421.24% |
| CervoMed Inc. | -2.17 Million USD | -20927.187% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -273.584% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3497.92% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -847.989% |
| Moolec Science SA | -52.07 Million USD | -776.965% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2564.437% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -250.242% |
| AnaptysBio, Inc. | -143.16 Million USD | -218.994% |
| Design Therapeutics, Inc. | -66.32 Million USD | -588.555% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -463.898% |
| NeurAxis, Inc. | -6.66 Million USD | -6752.492% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1109.759% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1148.794% |
| Achilles Therapeutics plc | -70.44 Million USD | -548.312% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -381.877% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1963.267% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 7934.357% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -18605.717% |
| Nutriband Inc. | -5.12 Million USD | -8816.515% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -316.121% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -723.863% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -803.43% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -599.609% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -743.993% |
| Palisade Bio, Inc. | -12.28 Million USD | -3618.622% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -906.444% |
| Beam Therapeutics Inc. | -156.47 Million USD | -191.861% |
| Neurogene Inc. | -52.28 Million USD | -773.435% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -234.592% |
| AEON Biopharma, Inc. | -48.36 Million USD | -844.323% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -390.963% |
| Sesen Bio, Inc. | -50.84 Million USD | -798.277% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -457.394% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3597.839% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -6.844% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -334.123% |
| Athira Pharma, Inc. | -116.7 Million USD | -291.322% |
| Vaccinex, Inc. | -19.74 Million USD | -2212.558% |
| HCW Biologics Inc. | -23.57 Million USD | -1837.067% |
| XOMA Corporation | -39.36 Million USD | -1060.215% |
| Nektar Therapeutics | -243.1 Million USD | -87.853% |
| Arvinas, Inc. | -394.8 Million USD | -15.675% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 242108.203% |
| Merus N.V. | -149.2 Million USD | -206.074% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -388.484% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1360.921% |
| Rezolute, Inc. | -68.42 Million USD | -567.442% |
| Clene Inc. | -43.24 Million USD | -956.137% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2861.214% |
| BeyondSpring Inc. | -21.54 Million USD | -2020.167% |
| Synlogic, Inc. | -55.16 Million USD | -727.911% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3679.558% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4191.336% |
| Peak Bio, Inc. | -1356.23 USD | -33672949.556% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1306.696% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2650.737% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -285.638% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -33.789% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -9814.051% |
| MannKind Corporation | 15.12 Million USD | 3118.6% |
| Ikena Oncology, Inc. | -74.39 Million USD | -513.847% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3526.491% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2346.687% |
| Gossamer Bio, Inc. | -172.15 Million USD | -165.28% |
| CohBar, Inc. | -12.06 Million USD | -3684.959% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1690.286% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1421.012% |
| Legend Biotech Corporation | -477.87 Million USD | 4.434% |
| Mural Oncology plc | -192.72 Million USD | -136.968% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -300.41% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2728.593% |
| Disc Medicine, Inc. | -91.02 Million USD | -401.713% |
| Champions Oncology, Inc. | -5.05 Million USD | -8936.09% |
| REGENXBIO Inc. | -239.46 Million USD | -90.711% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4160.833% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -719.076% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1077.984% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -304.84% |
| Vaxart, Inc. | -74.72 Million USD | -511.169% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1197.092% |
| Cellectis S.A. | -98.09 Million USD | -365.553% |
| Longeveron Inc. | -20.06 Million USD | -2176.59% |
| Repare Therapeutics Inc. | -114.27 Million USD | -299.643% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -3.982% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -510.442% |
| Revolution Medicines, Inc. | -430.58 Million USD | -6.062% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -7161.631% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1383.27% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -512.259% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 9414.379% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -4064.925% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 109.917% |
| Denali Therapeutics Inc. | -179.97 Million USD | -153.751% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -479569.776% |
| Veru Inc. | -89.97 Million USD | -407.564% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1599.1% |
| Cingulate Inc. | -22.95 Million USD | -1889.732% |
| Passage Bio, Inc. | -98.34 Million USD | -364.388% |
| Context Therapeutics Inc. | -25.06 Million USD | -1722.321% |
| Exicure, Inc. | -15.53 Million USD | -2838.954% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -121.622% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1135.082% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -7559.147% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -171.087% |
| Nuvalent, Inc. | -149.49 Million USD | -205.491% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -5515.601% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -431.683% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1413.301% |
| OmniAb, Inc. | -49.73 Million USD | -818.308% |
| Anew Medical, Inc. | -1.3 Million USD | -35006.854% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3593.659% |
| Lipocine Inc. | -16.32 Million USD | -2697.852% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -584.992% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -514.624% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1097.601% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1070.564% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1958.712% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 16.216% |
| Ocugen, Inc. | -64.82 Million USD | -604.466% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -393.339% |
| Q32 Bio Inc. | -86.5 Million USD | -427.946% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2597.962% |
| Alumis Inc. Common Stock | -156.89 Million USD | -191.085% |
| Equillium, Inc. | -12.13 Million USD | -3662.432% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -681.03% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5678.361% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2321.317% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -878.078% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -329.436% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2453.22% |
| Dominari Holdings Inc. | -22.44 Million USD | -1935.134% |
| Edesa Biotech, Inc. | -8.19 Million USD | -5476.021% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1697.119% |
| Bio-Techne Corporation | 326.66 Million USD | 239.803% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -18.661% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 311.048% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -248.327% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1120.069% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -202.238% |
| Nkarta, Inc. | -120.48 Million USD | -279.051% |
| BioCardia, Inc. | -11.56 Million USD | -3850.554% |
| Iterum Therapeutics plc | -34.58 Million USD | -1220.659% |